Staphylococcus aureus(MSSA), 44–80%71947 |
Kingella kingae, 14–50% (increased <36 months)71922242548
|
Rare |
Methicillin-resistant S aureus, 40–50% in USA, rare in UK4950 |
PVL MSSA1727 |
GAS |
GBS (neonates)1151 |
Non-typeable Haemophilus spp. (incidence unknown) |
Haemophilus influenzae type b (non-immunised or immunodeficient) |
Escherichia coli (neonates)1151 |
Streptococcus pneumoniae52 |
Coagulase negative staphylococcus (subacute) |
Very rare at any age (increased in immunodeficiency and where specific risk factors occur) |
Pseudomonas aeruginosa (usually inoculation injuries and therefore >1 year old) |
Neisseria gonorrhoeae |
Neisseria menigitidis (neonate, adolescent) |
Mycobacterium tuberculosis (older children as OAI develops 2 years from primary infection) |
Salmonella spp. (sickle cell disease)53 |
Non-tuberculous mycobacteria (associated with defects of IFNg/IL12 pathway) |
Klebsiella spp. |
Bartonella henselae |
Fusobacterium (often multifocal) |
Aspergillus |
Candida albicans (neonate, damaged bone) |